(Q42555875)

English

Increased matrix proteins, collagen and transforming growth factor are early markers of hepatotoxicity in patients on long-term methotrexate therapy

scientific article published on January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Increased matrix proteins, collagen and transforming growth factor are early markers of hepatotoxicity in patients on long-term methotrexate therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jaskiewicz K

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Voigt H

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Blakolmer K

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Journal of Toxicology: Clinical Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

301-305

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose Regimens

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Methotrexate induced liver disease in psoriasis

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Long-term methotrexate therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Toxic hepatic injury is associated with proliferation of portal nerve fibers

1 reference

https://api.crossref.org/works/10.3109%2F15563659609013794

21 January 2018

Identifiers

10.3109/15563659609013794

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42555875&oldid=2077631842"